Amryt Pharma (AMYT) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free AMYT Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comAmryt Pharma (LON:AMYT) Shares Pass Below Fifty Day Moving Average of $143.00March 22, 2023 | finance.yahoo.comAmryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi FarmaceuticiJanuary 16, 2023 | msn.comChiesi Farmaceutici S.p.A. to acquire Amryt PharmaJanuary 10, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Amryt Pharma Plc BuyoutJanuary 9, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBOJanuary 9, 2023 | technews.tmcnet.comAMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to ShareholdersJanuary 8, 2023 | news.yahoo.comItaly's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion dealJanuary 8, 2023 | au.finance.yahoo.comChiesi Farmaceutici S.p.A. to Acquire Amryt Pharma PlcDecember 5, 2022 | ca.finance.yahoo.comEuropean Commission approves Mycapssa® for the treatment of AcromegalyOctober 31, 2022 | nz.finance.yahoo.comAmryt Supports Acromegaly Awareness Day 2022October 17, 2022 | finance.yahoo.comAmryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)October 15, 2022 | seekingalpha.comAMYT Amryt Pharma plcAugust 6, 2022 | seekingalpha.comAmryt Pharma plc (AMYT) CEO Joseph Wiley on Q2 2022 Results - Earnings Call TranscriptAugust 4, 2022 | finance.yahoo.comAmryt Pharma PLC Sponsored ADR (AMYT) Reports Q2 Loss, Tops Revenue EstimatesJuly 30, 2022 | morningstar.comAmryt Pharma PLC ADR Stock Quote AMYTJune 27, 2022 | seekingalpha.comAmryt Pharma appoints Dr Tracy Cunningham as Chief Medical OfficerJune 25, 2022 | marketwatch.comAmryt to Pursue Formal FDA Resolution for Oleogel-S10 >AMYTJune 24, 2022 | finance.yahoo.comFilsuvez's European Approval Adds Growth Driver For Amryt PharmaJune 24, 2022 | nasdaq.comAmryt Pharma To Submit Formal Dispute Resolution Request For Oleogel-S10 NDAMay 17, 2022 | finance.yahoo.comAmryt Announces Details of EMA Contingent Value Rights PaymentMay 11, 2022 | uk.finance.yahoo.comAmryt Announces New Patent for Mycapssa®May 8, 2022 | seekingalpha.comAmryt Pharma PLC (AMYT) CEO Joseph Wiley on Q1 2022 Results - Earnings Call TranscriptApril 22, 2022 | seekingalpha.comAmryt stock rises 10% as EMA panel backs approval of Filsuvez to treat skin disorder in EUApril 13, 2022 | finance.yahoo.comAmryt Posts Long-Term Safety, Efficacy Mycapssa Data In Acromegaly PatientsMarch 17, 2022 | nasdaq.comAmryt Pharma PLC Rings the Opening BellMarch 8, 2022 | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Amryt Pharma plc (AMYT) on Behalf of InvestorsMarch 8, 2022 | benzinga.comA Preview Of Amryt Pharma's EarningsMarch 8, 2022 | uk.finance.yahoo.comAmryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules)March 3, 2022 | apnews.comKirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Amryt Pharma plc (AMYT) InvestorsFebruary 28, 2022 | baystreet.caAmryt Down on FDA ContactFebruary 28, 2022 | finance.yahoo.comAmryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDAJanuary 18, 2022 | finance.yahoo.comAmryt Announces New Patents for Oleogel-S10December 11, 2021 | finance.yahoo.comTimothy P. Lynch’s Stonepine Capital Portfolio: Top 10 Healthcare StocksNovember 23, 2021 | markets.businessinsider.comAmryt's Skin Disorder Drug Application Review With FDA Extended By Three MonthsNovember 23, 2021 | finance.yahoo.comAmryt Provides Update on Regulatory Review Process for Oleogel-S10November 3, 2021 | finance.yahoo.comAmryt Reports Strong Q3 2021 ResultsSeptember 30, 2021 | markets.businessinsider.comAmryt Pharma PLC : Amryt Supports Global FH Awareness DaySeptember 13, 2021 | finance.yahoo.comAmryt Raises Full Year 2021 Revenue Guidance to $220M - $225MSeptember 11, 2021 | fool.co.ukCheap UK shares: 1 I am considering right nowAugust 13, 2021 | barrons.comAmryt Pharma PLC ADRAugust 11, 2021 | proactiveinvestors.comAmryt Pharma PLC - Holding(s) in CompanyAugust 6, 2021 | finance.yahoo.comAmryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance Get Amryt Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… AMYT Media Mentions By Week AMYT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMYT News Sentiment▼0.670.55▲Average Medical News Sentiment AMYT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMYT Articles This Week▼10▲AMYT Articles Average Week Get Amryt Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alliance Pharma News Today Allergy Therapeutics News Today Animalcare Group News Today Advanced Medical Solutions Group News Today MaxCyte News Today PureTech Health News Today Oxford Biomedica News Today Medica Group News Today Bioventix News Today Tristel News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AMYT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe #1 Investment of the Decade… Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Nvidia WarningAltimetryThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amryt Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
